ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Drugmaker Novo Nordisk freezes hiring for non-critical jobs
Novo Nordisk, the maker of Wegovy, has initiated a global hiring freeze for non-critical roles amid increasing competition and pressure from Eli Lilly. This decision follows a profit warning that led to a significant drop in market value and the appointmen
Announcement as on 20 August 2025

Novo Nordisk stock climbs after FDA approves Wegovy to treat liver ailment

Announcement as on 18 August 2025

European shares on track for biggest weekly gain in 12; Novo Nordisk rises
European shares edged higher and were on track for their biggest weekly gain in 12 as investors assessed U.S. President Donald Trump's nomination for Federal Reserve's open spot on its governing board.
Announcement as on 08 August 2025

Novo Nordisk's Wegovy, Mounjaro sales in India double on month in July
Sales of Novo Nordisk's Wegovy and Eli Lilly's Mounjaro in India doubled in July, according to Pharmarack data. Wegovy, launched in June, saw sales more than double to 5,000 units, while Mounjaro sales also doubled to 157,000 units. Mounjaro's sales have s
Announcement as on 07 August 2025

Wegovy maker Novo Nordisk to reduce costs after billion stock loss
Wegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit warning and new CEO announcement last week wiped some billion of value from the company's stock.
Announcement as on 06 August 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.72
  • 12Day Average: 38.35
  • 20Day Average: 38.67
  • 50Day Average: 48.55
  • 100Day Average: 48.98
  • 150Day Average: 51.37
  • 200Day Average: 55.17

NVO Indicators & signals

Indicator MACD (12,26,9)

38.44, 41.25, -3.17
Indicator MACD is in negative zone

Indicator ADX (14)

40.66, 16.36, 38.79
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Fri Mar 2026 36.54 35.86 to 37.33 -1.43% 1.42 times
19 Thu Mar 2026 37.07 36.17 to 37.47 -3.56% 1.13 times
17 Tue Mar 2026 38.44 38.30 to 39.27 -0.36% 0.65 times
16 Mon Mar 2026 38.58 37.79 to 38.59 1.63% 0.74 times
13 Fri Mar 2026 37.96 37.70 to 38.80 -0.16% 0.74 times
12 Thu Mar 2026 38.02 37.85 to 39.02 -2.14% 1.1 times
11 Wed Mar 2026 38.85 38.36 to 39.13 0.34% 0.66 times
10 Tue Mar 2026 38.72 38.18 to 39.22 -2.76% 1.34 times
09 Mon Mar 2026 39.82 37.68 to 39.88 3.21% 1.26 times
06 Fri Mar 2026 38.58 38.17 to 38.85 -1.25% 0.99 times
05 Thu Mar 2026 39.07 38.08 to 39.12 1.48% 1.39 times
04 Wed Mar 2026 38.50 37.29 to 38.60 5.02% 1.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top